NucleoSeq Based Bacterial Detection: Fast, Precise, and Reliable

This patented nucleic acid based diagnostic method utilizes primers, probes, and kits specifically designed to detect identify a wide range important bacterial organismsincluding Legionella pneumophila, Acinetobacter baumannii, Mycoplasma pneumoniae, Mycobacterium avium, Mycobacterium intracellulare, Haemophilus influenzae, Listeria grayi and Mycobacterium tuberculosis, which are associated with severe respiratory and systemic infections. The invention provides both qualitative and quantitative results, offering a versatile platform for bacterial detection.

• Rapid & Accurate Detection: Detects bacterial pathogens faster and more precisely than traditional culture-based methods.
• High Specificity: Reduces false positives, ensuring reliable identification of harmful bacteria.
• Broad Applicability: Suitable for clinical diagnostics, food safety, environmental monitoring, and research.
• Early Detection: Enables timely treatment and infection prevention, improving patient outcomes.

Applications

• Healthcare Protection: Helps diagnose infections and prevents bacterial contamination in clinical products like blood supplies.
• Food & Water Safety: Identifies harmful bacteria in food, drinking water, and supply chains to prevent outbreaks.
• Environmental Monitoring: Detects bacterial contamination in hospitals, recreational water bodies, and public spaces to mitigate health risks.
• Public Health Impact: Provides a reliable solution for Infection Prevention and Control (IPC), monitor outbreaks, and reduces product contamination-related illnesses.

Desired business relationship

Technology selling

Patent licensing

Technology development

New technology applications

Adaptation of technology to other markets

Current development status

Laboratory prototypes